Vaccinating Plants? Nuclera Raises $75M + bit.bio Gets Good Patent News

Hi ,

Have you been to synbiobeta.com recently? Well, after months of hard work and collaboration, we've just unveiled our brand-new website design! We've reimagined our digital home with you in mind—making it easier than ever to navigate the latest news, insights, and breakthroughs in synthetic biology. The fresh design reflects the innovative spirit of our incredible community, and we can't wait for you to explore it. So please, dive in, take a look around, and let us know what you think. Your feedback is what drives us forward!

Paul Stamets on SynBioBeta: A Hub for New Talent

Paul Stamets highlights SynBioBeta as the ideal place for discovering new talent and building teams. Join us in 2025 for unparalleled networking and collaboration opportunities.

Check Out Our Latest Sponsors and Exhibitors for SynBioBeta 2025!

Who Just Registered to Attend SynBioBeta 2025?

Induced Resistance: Could "Vaccinating" Plants Help Us Outgrow Pesticides?

Scientists are exploring induced resistance, a promising approach to protecting crops by activating their natural immune systems—leading to healthier food and more sustainable farming.

bit.bio's opti-ox™ Tech Gains Unprecedented Global Patent Coverage

The European Patent Office upholds bit.bio's opti-ox™ patent, affirming the transformative power of their cell programming technology for future medical breakthroughs.

Nuclera Secures $75 Million to Accelerate Protein Expression and Purification in Drug Discovery

Nuclera’s $75 million financing will drive the global rollout of its eProtein Discovery™ system, designed to speed up protein screening and production for research.